Thrivent Financial for Lutherans
TVTX icon

Thrivent Financial for Lutherans’s Travere Therapeutics TVTX Stock Holding History

Thrivent Financial for Lutherans’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,986
Closed -$343K – 2664
2025
Q4 		$343K Buy
+8,986
New +$292K ﹤0.01% 2373
2023
Q3 		– Sell
-171,115
Closed -$2.63M – 2499
2023
Q2 		$2.63M Sell
171,115
-92,384
-35% -$1.68M 0.01% 1172
2023
Q1 		$5.93M Buy
263,499
+95,562
+57% +$2.03M 0.01% 756
2022
Q4 		$3.53M Buy
167,937
+2,403
+1% +$50.9K 0.01% 926
2022
Q3 		$4.08M Buy
165,534
+9,960
+6% +$257K 0.01% 858
2022
Q2 		$3.77M Sell
155,574
-27,679
-15% -$696K 0.01% 916
2022
Q1 		$4.72M Sell
183,253
-187
-0.1% -$4.96K 0.01% 912
2021
Q4 		$5.69M Sell
183,440
-79,352
-30% -$2.23M 0.01% 848
2021
Q3 		$6.37M Buy
+262,792
New +$4.83M 0.01% 813
2021
Q2 		– Sell
-247,011
Closed -$6.17M – 2525
2021
Q1 		$6.17M Buy
247,011
+82,628
+50% +$2.28M 0.01% 837
2020
Q4 		$4.48M Buy
164,383
+105,861
+181% +$2.47M 0.01% 904
2020
Q3 		$1.08M Buy
+58,522
New +$1.14M ﹤0.01% 1527

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Thrivent Financial for Lutherans's TVTX Position: Q1 2026 in Review

Thrivent Financial for Lutherans sold out of Travere Therapeutics (TVTX) in Q1 2026, closing a stake of 8,986 shares — an estimated $343K sold.

Thrivent Financial for Lutherans first reported a position in TVTX in Q3 2020 and held it in 12 quarters. The position peaked at $6.37M in Q3 2021. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

  • Thrivent Financial for Lutherans reported no remaining Travere Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 8,986 Travere Therapeutics shares in Q1 2026, an estimated $343K.
  • Thrivent Financial for Lutherans first reported a position in Travere Therapeutics in Q3 2020 and held it in 12 quarters.
  • Thrivent Financial for Lutherans's Travere Therapeutics position peaked at $6.37M in Q3 2021.
  • 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.